Cochlear inner hair cell specific promoter and use thereof

By using the specific promoter sequence of the inner hair cell and AAV viral vector in the cochlear inner hair cells, the specific expression of the transgene is achieved, and the problem of insufficient gene therapy efficiency and safety of the cochlear inner hair cell in the prior art is solved, which significantly Improves the therapeutic effect of hereditary hearing loss.

WO2024234966A1PCT designated stage expired Publication Date: 2024-11-21OTOVIA THERAPEUTICS

Patent Information

Application Number
PCT/CN2024/089833
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-12
Filing Date
2024-04-25
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

The prior art is difficult to achieve specific gene expression in cochlear hair cells, resulting in fewer methods of treating hereditary hearing loss, and insufficient efficiency and safety of gene therapy.

Method used

A specific promoter sequence for inner hair cells was developed to efficiently express transgenes in cochlear inner hair cells. The promoter sequence was introduced into cochlear inner hair cells through AAV viral vector to achieve specific expression of transgenes and reduce the risk of off-targeting. , improve treatment efficiency and safety.

Benefits of technology

Through this technology, transgenes can be specifically expressed in cochlear hair cells, improving the efficiency and safety of gene therapy, effectively treating or preventing hereditary hearing loss, significantly improving the expression of related proteins in cochlear hair cells, and improving hearing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure PCTCN2024089833-FTAPPB-I100001
    Figure PCTCN2024089833-FTAPPB-I100001
  • Figure PCTCN2024089833-FTAPPB-I100002
    Figure PCTCN2024089833-FTAPPB-I100002
  • Figure PCTCN2024089833-FTAPPB-I100003
    Figure PCTCN2024089833-FTAPPB-I100003
Patent Text Reader

Abstract

Provided are a nucleic acid sequence that causes the specific expression of a gene in cochlear inner hair cells, and the use thereof in gene therapy, especially the use in the treatment of hereditary hearing impairment associated with defects in cochlear inner hair cells.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Materials and methods for delivering nucleic acids to cochlear and vestibular cells

    CN109310745A

  • Compositions and methods for treating non-age-associated hearing impairment in a human subject

    CN110225975A

  • Adeno-associated virus (AAV) containing variant capsid protein and application of AAV

    CN110437317A

  • Treatment of deafness by gene therapy

    CN111683688A

  • Treatment of deafness by gene therapy

    WO2019138030A1

Cited By

  • Compositions and methods for treating non-age-associated hearing impairment in a human subject

    US12673116B2